Quantum BioPharma hires IR Agency
Analysis based on 6 articles · First reported Jun 02, 2026 · Last updated Jun 02, 2026
The market may react positively to the increased visibility and investor awareness for Quantum BioPharma Ltd. due to the engagement of IR Agency LLC. This could potentially lead to increased trading volume and a more informed investor base for Quantum BioPharma Ltd.'s stock.
Quantum BioPharma Ltd., a biopharmaceutical company, announced an investor relations and consulting services agreement with Stocks.news through IR Agency LLC, effective June 8, 2026. For a fee of US$250,000 over six months, IR Agency LLC will provide services including creating company profiles, media distribution to the financial community, building a digital community, marketing news distribution, and lead generation campaigns. Rafael Pereira of IR Agency LLC will be involved in these services. The agreement aims to enhance Quantum BioPharma Ltd.'s visibility and attract potential investors.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard